Light Mode
$26.27 ↑ +0.00 (+0.00%) Trading Up from the previous close of $26.27, $0.18 below the day’s high of $26.45
+12.06 (+84.87%) / 6M
Momentum, market sentiment, and recent alerts
ADPT reads neutral: price sits above one of the two key moving averages, the 12-month move is +53.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.